Recent News

By Category: Public Health

The Use of New Replikins Synthetic Vaccines to Prevent Pandemics

(The Sacramento Bee) In the lead paper to be presented at the Influenza Congress USA in Washington DC on November 12, 2012, Dr. Samuel Bogoch of Bioradar UK Ltd. will discuss how new synthetic Replikin vaccines may prevent the development of influenza virus outbreaks and pandemics. Pandemic prevention, not previously possible, is being considered for Read More »

November 7, 2012
| Filed under North America, Agents & Toxins, Public Health, and Research
Share

Advancing Transient Passive Immunity for Biothreats

(Global Biodefense) The Defense Advanced Research Projects Agency (DARPA) is seeking innovative methods of scalable passive immunization to protection personnel for a period of time, suitable to a military mission requirement or in a public health setting. Towards this goal, the agency is soliciting proposals for the development of nucleic acid platforms capable of in Read More »

November 6, 2012
| Filed under North America, Agents & Toxins, Bioterrorism, Countermeasures, Policy & Initiatives, and Public Health
Share

Heroin user treated for anthrax in 12th confirmed case of disease in Europe since June

(Birmingham Mail) A drug user has been taken to hospital with anthrax infection after injecting a suspected contaminated batch of heroin. The case in Oxford follows the deaths of two people who injected drugs from a confirmed anthrax infection in Blackpool in August and September. The Health Protection Agency (HPA) said it was the 12th Read More »

November 5, 2012
| Filed under Europe, North America, Agents & Toxins, and Public Health
Share

CDC issues travel notice for Uganda due to Marburg outbreak

(The Examiner) With the Marburg hemorrhagic fever (HF) outbreak spreading in Uganda, now being reported from 5 districts in the African country, federal health officials have issued an advisory for travelers to Uganda, according to a Centers for Disease Control and Prevention (CDC) travel notice Nov.2 The Uganda Ministry of Health officially declared an outbreak Read More »

November 5, 2012
| Filed under Africa, North America, International, and Public Health
Share

Treatment for inhalation anthrax, raxibacumab, gets through FDA committee

(The Examiner) An injectable drug for the treatment of inhalation anthrax has been recommended by the Anti-Infective Drugs Advisory Committee for Food and Drug Administration (FDA) approval, according to a GlaxoSmithKline press release Nov. 2. The drug, raxibacumab injection, is a monoclonal antibody targeting the protective antigen (PA) component of the lethal toxin of Bacillus Read More »